Fellowship · Houston, TX
Sponsored by University of Texas M D Anderson Cancer Center
Small Cell Lung Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology.
Journal of the National Comprehensive Cancer Network : JNCCN · 2021 · 442 citations · Cesar Moran
Proton versus photon radiotherapy for patients with oropharyngeal cancer in the USA: a multicentre, randomised, open-label, non-inferiority phase 3 trial.
Lancet (London, England) · 2026 · 35 citations · Adel El-Naggar
Neoadjuvant nivolumab or nivolumab plus ipilimumab in operable non-small cell lung cancer: the phase 2 randomized NEOSTAR trial.
Nature medicine · 2021 · 558 citations · Annikka Weissferdt, Neda Kalhor
Proteogenomic insights into the biology and treatment of HPV-negative head and neck squamous cell carcinoma.
Cancer cell · 2021 · 295 citations · Adel El-Naggar
Neoadjuvant chemotherapy plus nivolumab with or without ipilimumab in operable non-small cell lung cancer: the phase 2 platform NEOSTAR trial.
Nature medicine · 2023 · 206 citations · Annikka Weissferdt
Multimodal spatial-omics reveal co-evolution of alveolar progenitors and proinflammatory niches in progression of lung precursor lesions.
Cancer cell · 2026 · 19 citations · Neda Kalhor
Differentiating Separate Primary Lung Adenocarcinomas From Intrapulmonary Metastases With Emphasis on Pathological and Molecular Considerations: Recommendations From the International Association for the Study of Lung Cancer Pathology Committee.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer · 2025 · 34 citations · Annikka Weissferdt
CD70 is a therapeutic target upregulated in EMT-associated EGFR tyrosine kinase inhibitor resistance.
Cancer cell · 2023 · 103 citations · Cesar Moran